B. Bourbigot

2.0k total citations
33 papers, 1.3k citations indexed

About

B. Bourbigot is a scholar working on Transplantation, Psychiatry and Mental health and Surgery. According to data from OpenAlex, B. Bourbigot has authored 33 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Transplantation, 11 papers in Psychiatry and Mental health and 6 papers in Surgery. Recurrent topics in B. Bourbigot's work include Renal Transplantation Outcomes and Treatments (17 papers), Neurological Complications and Syndromes (10 papers) and Pharmacological Effects and Toxicity Studies (6 papers). B. Bourbigot is often cited by papers focused on Renal Transplantation Outcomes and Treatments (17 papers), Neurological Complications and Syndromes (10 papers) and Pharmacological Effects and Toxicity Studies (6 papers). B. Bourbigot collaborates with scholars based in France, United States and Switzerland. B. Bourbigot's co-authors include Scott B. Campbell, Š Vı́tko, Josette Eris, A.-M. Stoppa, Pierre Quartier, Bruno Hurault de Ligny, Yves Réguerre, J. L. Garnier, B. Vasseur and C. Antoine and has published in prestigious journals such as The Journal of Urology, Annals of Oncology and Transplantation.

In The Last Decade

B. Bourbigot

33 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B. Bourbigot France 16 659 402 344 315 200 33 1.3k
L Frödin Sweden 14 469 0.7× 408 1.0× 327 1.0× 253 0.8× 106 0.5× 64 1.2k
I.A. Hauser Germany 14 442 0.7× 264 0.7× 173 0.5× 508 1.6× 181 0.9× 30 1.2k
Fu L. Luan United States 21 790 1.2× 518 1.3× 247 0.7× 333 1.1× 214 1.1× 40 1.4k
Yoshihiko Watarai Japan 21 799 1.2× 570 1.4× 201 0.6× 253 0.8× 132 0.7× 141 1.6k
Marie‐Noelle Péraldi France 23 404 0.6× 327 0.8× 438 1.3× 400 1.3× 60 0.3× 51 1.6k
K. Tanabe Japan 20 669 1.0× 494 1.2× 191 0.6× 232 0.7× 88 0.4× 113 1.3k
Lluís Guirado Spain 21 427 0.6× 318 0.8× 148 0.4× 218 0.7× 79 0.4× 70 1.2k
Domingo del Castillo Spain 13 918 1.4× 498 1.2× 190 0.6× 326 1.0× 262 1.3× 21 1.3k
V. Ram Peddi United States 15 779 1.2× 380 0.9× 149 0.4× 234 0.7× 152 0.8× 29 1.1k
J S Najarian United States 15 237 0.4× 327 0.8× 429 1.2× 239 0.8× 50 0.3× 42 1.2k

Countries citing papers authored by B. Bourbigot

Since Specialization
Citations

This map shows the geographic impact of B. Bourbigot's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Bourbigot with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Bourbigot more than expected).

Fields of papers citing papers by B. Bourbigot

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B. Bourbigot. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Bourbigot. The network helps show where B. Bourbigot may publish in the future.

Co-authorship network of co-authors of B. Bourbigot

This figure shows the co-authorship network connecting the top 25 collaborators of B. Bourbigot. A scholar is included among the top collaborators of B. Bourbigot based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B. Bourbigot. B. Bourbigot is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Glotz, Denis, Bernard Charpentier, Daniel Abramovicz, et al.. (2010). Thymoglobulin Induction and Sirolimus Versus Tacrolimus in Kidney Transplant Recipients Receiving Mycophenolate Mofetil and Steroids. Transplantation. 89(12). 1511–1517. 50 indexed citations
2.
Choukroun, Gabriel, Gilbert Deray, Denis Glotz, et al.. (2008). Incidence et prise en charge de l’anémie en transplantation rénale : une étude observationnelle française. Néphrologie & Thérapeutique. 4(7). 575–583. 8 indexed citations
3.
Mourad, Georges, Alexandre Karras, Nassim Kamar, et al.. (2007). Renal function with delayed or immediate cyclosporine microemulsion in combination with enteric‐coated mycophenolate sodium and steroids: results of follow up to 30 months post‐transplant. Clinical Transplantation. 21(3). 295–300. 10 indexed citations
4.
Pietruck, Frank, Klemens Budde, Maurizio Salvadori, et al.. (2006). Efficacy and safety of enteric‐coated mycophenolate sodium in renal transplant patients with diabetes mellitus: post hoc analyses from three clinical trials. Clinical Transplantation. 21(1). 117–125. 13 indexed citations
5.
Tedesco‐Silva, Hélio, Š Vı́tko, Julio Pascual, et al.. (2006). 12-month safety and efficacy of everolimus with reduced exposure cyclosporine in de novo renal transplant recipients. Transplant International. 20(1). 27–36. 88 indexed citations
6.
Frimat, Luc, E. Cassuto‐Viguier, B Charpentier, et al.. (2006). Impact of Cyclosporine Reduction With MMF: A Randomized Trial in Chronic Allograft Dysfunction. The ‘Reference’ Study. American Journal of Transplantation. 6(11). 2725–2734. 48 indexed citations
7.
Krämer, Bernhard K., H. H. Neumayer, B. Krüger, et al.. (2005). Graft Function, Cardiovascular Risk Factors, and Sex Hormones in Renal Transplant Recipients on an Immunosuppressive Regimen of Everolimus, Reduced Dose of Cyclosporine, and Basiliximab. Transplantation Proceedings. 37(3). 1601–1604. 41 indexed citations
8.
Segall, Liviu, et al.. (2005). Toxoplasmosis-associated hemophagocytic syndrome in renal transplantation. Transplant International. 19(1). 78–80. 25 indexed citations
9.
Quinio, Dorothée, et al.. (2004). Zygomycosis caused byCunninghamella bertholletiaein a kidney transplant recipient. Medical Mycology. 42(2). 177–180. 38 indexed citations
10.
Vı́tko, Š, Hélio Tedesco‐Silva, Josette Eris, et al.. (2004). Everolimus with Optimized Cyclosporine Dosing in Renal Transplant Recipients: 6-Month Safety and Efficacy Results of Two Randomized Studies. American Journal of Transplantation. 4(4). 626–635. 207 indexed citations
11.
12.
Kovarik, John M., P. Wolf, G. Mourad, et al.. (1997). DISPOSITION OF BASILIXIMAB, AN INTERLEUKIN-2 RECEPTOR MONOCLONAL ANTIBODY, IN RECIPIENTS OF MISMATCHED CADAVER RENAL ALLOGRAFTS1. Transplantation. 64(12). 1701–1705. 99 indexed citations
13.
Giral, Magali, Véronique M. Braud, B. Bourbigot, et al.. (1995). EFFECTS OF MHC-ENCODED TAP1 AND TAP2 GENE POLYMORPHISM AND MATCHING ON KIDNEY GRAFT REJECTION. Transplantation. 60(3). 292–295. 17 indexed citations
14.
Moal, Marie‐Christine, et al.. (1995). Fulminant hepatitis revealing primary varicella in a renal graft recipient.. PubMed. 27(4). 2512–2512. 6 indexed citations
15.
Henry, Alastair, et al.. (1994). High incidence of neurologic complications following rapid correction of severe hyponatremia in polydipsic patients.. PubMed. 55(8). 349–54. 40 indexed citations
16.
Baatard, R., F. Pradier, Jacques Dantal, et al.. (1993). PROSPECTIVE RANDOMIZED COMPARISON OF UNIVERSITY OF WISCONSIN AND UW-MODIFIED, LACKING HYDROXYETHYL-STARCH, COLD-STORAGE SOLUTIONS IN KIDNEY TRANSPLANTATION. Transplantation. 55(1). 31–35. 21 indexed citations
17.
Pennec, Yvon, et al.. (1993). Salt Wastage, Plasma Volume Contraction and Hypokalemic Paralysis in Self-Induced Water Intoxication. ˜The œNephron journals/Nephron journals. 64(4). 570–575. 7 indexed citations
18.
Mabin, Dominique, et al.. (1993). [Regressive leukoencephalopathy induced by an overdose of cyclosporine A].. PubMed. 149(10). 576–8. 2 indexed citations
19.
Vernillet, Laurent, et al.. (1992). Lack of effect of isradipine on cyclosporin pharmacokinetics. Fundamental and Clinical Pharmacology. 6(8-9). 367–374. 5 indexed citations
20.
Bourbigot, B., et al.. (1990). Captopril induces correction of postrenal transplant erythremia. Transplant International. 3(4). 222–225. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L Frödin Breakdown of academic impact, for papers by I.A. Hauser Breakdown of academic impact, for papers by Fu L. Luan Breakdown of academic impact, for papers by Yoshihiko Watarai Breakdown of academic impact, for papers by Marie‐Noelle Péraldi Breakdown of academic impact, for papers by K. Tanabe Breakdown of academic impact, for papers by Lluís Guirado Breakdown of academic impact, for papers by Domingo del Castillo Breakdown of academic impact, for papers by V. Ram Peddi Breakdown of academic impact, for papers by J S Najarian
Rankless by CCL
2026